Balixafortide

CAT: 0804-HY-P1682-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-P1682-01Size:5 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Balixafortide (POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 CXCR4 than a large panel of receptors including CXCR7. Balixafortide blocks β-arrestin recruitment and calcium flux with IC50s [1][2].
CAS Number
[1051366-32-5]
Product Name Alternative
POL6326
UNSPSC
12352209
Target
Arrestin; CXCR
Type
Peptides
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/balixafortide.html
Purity
98.20
Solubility
DMSO : 25 mg/mL (ultrasonic) |H2O : ≥ 50 mg/mL
Smiles
O=C(N(CCC1)[C@]1([H])C(N[C@H](C(N[C@H](C(N[C@H]2C)=O)CC3=CN=CN3)=O)CC(C=C4)=CC=C4O)=O)[C@](CCC5)([H])N5C([C@@H](NC([C@@H](NC([C@@H](NC([C@@](CSSC[C@](C(N[C@H](C(N[C@H](C(N6[C@]7([H])CCC6)=O)C)=O)CO)=O)([H])NC2=O)([H])NC([C@@H](NC([C@@H](NC([C@@H](NC7=O)CCN)=O)CCCNC(N)=N)=O)CC(C=C8)=CC=C8O)=O)=O)CC(C=C9)=CC=C9O)=O)CCC(N)=O)=O)CCCCN)=O
Molecular Formula
C84H118N24O21S2
Molecular Weight
1864.11
References & Citations
[1]Zimmermann J, et al. Anti-tumor cell activity and in vitro profile of the next generation CXCR4 antagonist Balixafortide. Ann Oncol. 2018 Oct;29 Suppl 8:viii103.|[2]Karpova D, et al. Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial. J Transl Med. 2017 Jan 3;15 (1) :2.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Phase 3
Isoform
CXCR4

Popular Products